Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | ![]() FDA Accepts Virtual Life Management® for Evaluation Into The MDDT Pilot ProgramThe FDA will work together with VEXTEC to meet the criteria for the proposed program – a Virtual Twin® software of the medical device that manufacturers and the FDA use to assess and measure performance, safety and effectiveness. Once qualified by the FDA, VLM can then be used by the medical device industry in support of their device submissions to the Agency as well as by the FDA to review these premarket applications, potentially reducing time and other resources needed to develop new products. The specific application will be to use VLM as a computational modeling tool to simulate the structural reliability of a component, assembly or system pertaining to a medical device in terms of the probability of failure. The appropriateness of this tool is based on FDA’s preliminary assessment of status of the VLM tool for reducing the design-build- The core technology within VLM’s reliability prediction software is its probabilistic integration of structural analysis with material microstructural damage simulation and field test setup. VLM has a library of software modules and material models used to simulate the required combination of material and device in a particular use condition. The software allows for three dimensional analysis that is multi-scale in size and time. VEXTEC (www.vextec.com) End
|
|